Chronic direct renin inhibition with aliskiren prevents the development of hypertension in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent hypertension

American Journal of the Medical Sciences

Volumn 344, Issue 4, 2012, Pages 301-306

  Huang, Lily ^a   Howard, Catherine G ^a   Mitchell, Kenneth D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney; Renal hemodynamics; Renin inhibitor; Renin angiotensin system; Sodium excretion

Indexed keywords

3 INDOLEMETHANOL; ALISKIREN; ANGIOTENSIN II;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; PLETHYSMOGRAPHY; RAT; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 84866942004     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182410d1e     Document Type: Article

References (23)

1. Kantachuvesiri S, Fleming S, Peters J, et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 2001;276:36727-"33.
2. Campbell SJ, Carlotti F, Hall PA, et al. Regulation of the CYP1A1 promoter in transgenic mice: An exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 1996;109:2619-"25.
3. Forrester LM, Henderson CJ, Glancey MJ, et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 1992;281:359-"68.
4. Smith JD, Wong E, Ginsberg M. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc Natl Acad Sci U S A 1995; 92:11926-"930.
5. Gelboln HV. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980;60:l107-"66.
6. Jelllnck PH, Forkert PG, Riddick DS, et al. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 1993;45:1129-"36.
7. Loub WD, Wattenberg LW, Davis DW. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. JNatl Cancer Inst 1975;54:985-"8.
8. Pelkonen O, Nebert DW. Metabolism of polycyclic aromatic hydrocarbons: Etiologic role in carcinogenesis. Pharmacol Rev 1982;34:189-"222.
9. Fujii-Kuriyama Y, Masatsuga E, Junsei M, et al. Polymorphic forms of the Ah receptor and induction of the CYP1A1 gene. Pharmacogenetics 1995;5:149-"53.
10. Mitchell KD, Bagatell SJ, Miller CS, et al. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyplal-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst 2006;7:74-"86.
11. Howard LL, Patterson ME, Mullins JJ, et al. Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyplal-Ren2 transgenic rats. Am J Physiol Renal Physiol 2005;228:F810-"5.
12. Opay AL, Mouton CR, Mullins JJ, et al. Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG-dependent malignant hypertension. Am J Physiol Renal Physiol 2006;291:F612-"8.
13. Graciano ML, Mouton CR, Patterson ME, et al. Renal vascular and tubulointerstitial inflammation and proliferation in Cyplal-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol 2007;292:F1858-"66.
14. Williams DE, Prieto MC, Mullins JJ, et al. ATI receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyplal-Ren2 transgenic rats fed with a high-salt diet. Am J Med Sci 2010;339:356-"61.
15. Milani CJ, Kobori H, Mullins JJ, et al. Enhanced urinary angiotensinogen excretion in Cyplal-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Med Sci 2010;340: 389-"94.
16. Mitchell KD, Mullins JJ. Enhanced tubuloglomerular feedback in Cyplal-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol 2005;289:F1210-"6.
17. Pilz B, Shagdarsuren E, Wellner M, et al. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenicrats. Hypertension 2005;46:569-"76.
18. Feldman DL. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease. Hypertens Res 2010; 33:279-"87.
19. Whaley-Connell A, Habibi J, Cooper SA, et al. Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat. Am J Physiol Endocrinol Metab 2008;295:E103-"9.
20. Rakusan D, Kujal P, Kramer HJ, et al. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normal ization of glomerular area in Ren-2 transgenic rats. Am J Physiol Renal Physiol 2010;299:F758-"66.
21. Howard CG, Mullins JJ, Mitchell KD. Direct renin inhibition with aliskiren normalizes blood pressure in Cyplal-Ren2 transgenic rats with inducible angiotensin II-dependent malignant hypertension. Am J Med Sci 2011;341:383-"7.
22. Feldman DL, Jin L, Xuan H, et al. Effects of aliskiren on blood pressure, albuminuria, and (pro)renin receptor expression in diabetic TG(mRen-2)27 rats. Hypertension 2008;52:130-"6.
23. Feldman DL, Schuetz H, Persohn E, et al. Light microscopy autoradiographic localization of the renin inhibitor aliskiren in rat kidneys [abstract]. Hypertension 2010b;56:el09.